Janux Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
JANX Key Statistics
Stock Snapshot
The current Janux Therapeutics(JANX) stock price is $17.63, with a market capitalization of 1.08B. The stock trades at a price-to-earnings (P/E) ratio of -11.06.
On 2026-11-07, Janux Therapeutics(JANX) stock traded between a low of $16.14 and a high of $17.80. Shares are currently priced at $17.63, which is +9.2% above the low and -1.0% below the high.
Janux Therapeutics(JANX) shares are trading with a volume of 844.03K, against a daily average of 740.02K.
In the last year, Janux Therapeutics(JANX) shares hit a 52-week high of $35.34 and a 52-week low of $12.12.
In the last year, Janux Therapeutics(JANX) shares hit a 52-week high of $35.34 and a 52-week low of $12.12.
Analyst ratings
84%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.